Tidepool, an open-source diabetes non-profit founded in 2013 and driving community-led innovation, has thus made a reality the patient-led project, Tidepool Loop – the first iPhone-controlled interoperable automated glycaemic controller for T1D management of its kind to be given FDA clearance. It is also the first application to enable insulin delivery from a compatible Apple Watch.
The algorithm technology in Tidepool Loop is intended for use with compatible integrated continuous glucose monitors (iCGM) and alternate controller enabled (ACE) pumps, to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. Furthermore, it can recommend and deliver correction boluses when glucose values are predicted to exceed predefined thresholds.
